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T he epidermis is elegantly designed to provide a con-stantly renewing protective surface. The proliferating stem cel ls, which constantly replenish the epidermis, occupy the basal layer adjacent the basal lamina [1,2]. The supra basal spinous and granular layers contain 
11s that have largely lost proliferative potential, but are still living 
ce d functioning. These cells are undergoing a progressive process of ~ntracellular remodeling in preparation for terminal differentiation. r the stratum lucidum the remodeling is largely completed as the 
: ratinocytes pass from the living to the non-living state to form 
e neocytes [1,2]. Thus, the surface of the skin consists of a blanket 
cor h f ' h ' f interlinked corneocytes t at unctlon to protect t e orgamsm o . f om the envIronment. 
r The corneocyte, the functional unit of the stratum corneum, can 
b thought of as an envelope of cross-linked protein surrounding a 
e (Work of keratin intermediate filaments. A definmg feature of the 
nerneocyte envelope is its stability when challenged with heating at h~gh temperatures in the presence of reducing and chaotrojJhlc 
I ents [1,3 - 7J. This is due to the presence of E-(y-glutamyl)lysme, 
agotein-protein, cross-links [4,8]. These linkages are formed by the 
prtion of transglutaminases (TGs), enzymes that carry out acyl-
:cansfer reactions that transfer protein-bound glutamyl groups to r~e primary amine of a second protein [9 - .14] (Fig 1). Although our 
derstanding of envelope structure has mcreased m recent years, 
unr insight is, in many respects, still rudimentary. A great deal of ~lfort has been spent in identifying protein p.recursors of the enve-
lope [1,15 -20]. The present revIew wIll descnbeour current knowl-
edge of one envelope precursor, involucrin [21-24] . 
INVOLUCRIN IS AN ENVELOPE PRECURSOR 
Involucrin was first described by Rice and Green in 1979., They 
t eated cultured keratinocytes with membrane permeabliIzll1g a~ents that allow calcium influx and observed a calcium-depen.dent 
disappearance of a protein from the soluble phase [21]. The dlsap-
earance was inhibited by calcium chelators or inhibitors of TG. ~hey purified this protein, which they called involucrin, from cul-
tured human keratinocytes and generated ~ specific. antibedy [21]. 
Biochemical measurements suggested that II1volucnn wa.s an elo~­
gated (length: width, 30: 1) 83-kDa molecule. Ammo aCId ana lysIs 
indicated a high percentage (40%) of glx residues (glu + gin). Im-
munologic evidence suggested that involucrin was incorporated 
into the cornified envelope and the er.itope was detected in the 
upper layers of the epidermis il1l1illO [21 . In additien, small pnmary 
amines can be transferred to involucrin ill llitro by extracts prepared 
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'from cultured keratinocytes or fibroblasts [23] . This transfer is cal-
cium dependent and inhibited by TG inhibitors. Human involucrin 
has also been expressed in cultured rat keratinecytes, CHO cells, 
and PtK2 cells via vector-mediated gene transfer [24] . Elevation of 
intracellular calcium resulted in the disappearance of human inve-
lucrin frem the soluble phase in cells expressing keratinecyte (rat 
~eratinocytes) and tissue-type (CHO cells) transglutaminase, respec-
tIvely [24]. In each case the disappea rance was inhibitable by cal-
cium chelators or TG inhibitors. No disappearance from the soluble 
phase was observed in PtK2 cells, which express barely detectable 
levels of TG. These results suggest that invelucrin is an efficient 
substrate for both keratinocyte and tissue type transglutaminases. 
The identification of involucrin as an envelepe component has 
recently been confirmed using chemical cleavage methods to release 
involucrin fragments from highly purified cernified envelopes, as 
well as by immunoelectron microscopy [22]. 
INVOLUCRIN STRUCTURE 
Complimentary DNA and genomic clones encoding human invo-
lucnn were Isolated 111 1986 [15]. The protein sequence, determined 
from the cDNA sequence, has a repeating structure and a molecular 
weIght of 68,000 daltons [15] . This melecular weight is less than 
the estimat~ of 83 - 92 kDa reperted by Rice and Green [21] ; how-
ever, the dIscrepancy IS not surprising as involucrin is known to 
migrate anoma.lously in varieus gel systems [25]. The molecule 
consIsts of a senes of repeats, each consisting of ten amino acids and 
havi.n~ the ~onsensus sequence Q-E-G-Q-L-K-H-L-E-Q, and it can 
bedlvlded II1tO three major segments based on degree of identity to 
thIS consens~s sequence [15), The carboxy and amino terminal seg-
ments contall1 19 repeats that are 0 to 30% identical to the consen-
sus, wh~reas th~ central segment consists of 39 repeats that are 
50 - 100 Yo IdentIcal to the consensus [15]. Each of the central seg-
mel.lt repeats has~ 011 average, three glutamine residues, each of 
whIch IS a potentIal cross-linking site [15]. 
The structure .of human invelucrin has been investigated using 
computer modelIl1g, CIrcular dichroism, and electron microscepy 
[26]. Based on these results, a medel ofinvelucrin structure has been 
proposed (Fig 2). Computer modeling predicts that the entire cen-
tral segment and adjacent regions of the amino and carboxy terminal 
flankll1g segments are composed of long stretches of a-helix sepa-
rated by short random COIl segments [26]. The amino and carboxy 
ternllnal ends are predIcted to contain three and four fJ-sheet de-
mall1S, resflectively , with each fJ-sheet segment separated by a short 
r~ndom COI l segment [26]. The high a-hel ica l content is verified by 
CIrcular dIchrOIsm (CD) analysis, which indicates that at least 50% 
of th~ molecule is .a-helical. Electron micrescepic visualization .of 
negatIvely seamed Il1volucrin preparations reveals thin, flexible rods 
h~vll1g a mean cO~ltOur length of 460 A. Computer algorithms pre-
dIct a molecule WIth adequate a-helix to ferm a 660-A rod, whereas 
the CD spectrum predicts enough a-helix to fcrm a 440-A rod. The 
electron microscopic visualized length, 460 A, is censistent with 
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Figure 1. Transglutaminase-catalyzed formation 
of isopeptide bonds. TG, shown as an opell circle, is 
inactive in the absence of calcium and is anchored 
to the plasma membrane by a lipid anchor (vertical 
lille). Involucrin, shown as a solid rod, is a soluble 
protein (A) . In the presence of calcium, TG is acti-
vated (slladed circles) and forms an enzyme-acyl in-
volucrin intermediate (B) . The enzyme then 
transfers involucrin to a primary amine donated by 
a membrane-bound protein (C). The completed 
E-(y-g lu tamyl)lysinc protein-protein linkage is 
shown in D. 
TG~ 
H2N - C=O 
! 
A 
Ca++ 
the CD prediction . The axial ratio (i.e., length: width) is calculated 
to be 30: 1 [26]' a value identical to that of Rice and Green [21] . The 
central a-helical region is hydrophilic, whereas the flanking amino 
and carboxy terminal fJ-sheet regions are relatively hydrophobic 
[26]. · , 
These basic features of the involucrin structure appear to be con-
served across species. Involucrin molecules from a wide range of 
species have been characterized and their importance as markers of 
molecular evolution have been documented l27,28] . All involucrin 
molecul es are rich in glutamine and glutamic acid and, although the 
length of the repeat may vary, all involucrin molecules have a re-
peating structure [27,28] . However, the structural features that are 
required for function are not known, with one possible exception. 
All primate involucrin molecul es appear to share in common a cir-
cumferential distribution of glutamine residues along the length of 
the rod. Computer modeling studies suggest that changing the 
length of the repeating unit perturbs this distribution [26] and tends 
to cluster the glutamine residues along one face of the helix, a 
change that may have a negative impact on involucrin function by 
changing its so lubiliry and/or reducing its abi lity to cross- link other 
proteins. Such a change may make the molecule amphipathic, 
which could disturb its solubility, intracellular distribution, second-
ary structure, or other features that could effect function. The com-
monality of this circumferential distribution supports its impor-
tance for function; however, further studies using involucrin 
mutants will be necessary to confirm its importance. 
INVOLUCRIN AND CORNIFIED 
ENVELOPE ASSEMBLY 
Several factors are likely to define involucrin's role in envelope 
formation . First, involucrin is expressed relatively early in keratino-
cyte differentiation [21,29,30] in the suprabasal cell layers of the 
esophagus, epidermis, conjunctiva, cervix, and other stratifying tis-
sues [30]. In epidermis, it is produced in the spinous layer at an early 
stage in keratinocyte differentiation [21,31]. Other proteins in-
volved in envelope assembly display a suprabasal pattern of differen-
tiation-dependent expression; however, the time of initiation of 
synthesis and the subcellular distribution differ [11,32,33]. TG, the 
enzyme responsib le for cornified envelope formation, is expressed 
at about the same time during differentiation as involucrin [11]. 
One form of the enzyme is anchored to the inner surface of the 
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plasma membrane by a lipid anchor [34] and a second form is soluble 
[35]. Loricrin, an insoluble envelope precursor, is expressed later in 
the differentiation process and is contained in intracellular granules 
[32] . It is released from the granules in the granular and transition 
zones and is then utilized in envelope assembly [32]. Cornifin, a 
soluble precursor of the envelope, is located in the cytoplasmic 
compartment and has a pattern of expression during differentiation 
that is similar to that of involucrin [17] . Morphologic evidence 
indicates that the initial event in envelope assembly is the appear-
ance of a thickened band on the cytoplasmic side of the inner plasma 
membrane [36] . This is due to deposition of cross-linked protein and 
begins in the intermediate layers in mouse tongue at a time when 
the cells are still nucleated and have a full complement of cellular 
organelles [36] . Thus, initiation of assembly begins long before 
nuclear destruction is complete. The synthesis of involucrin early in 
differentiation suggests that it is likely to be deposited early in 
envelope assembly. Moreover, its continued synthesis in supra-spin-
ous layer cells suggests that additional involucrin molecules are 
likely to be deposited as envelope assembly continues. 
Second, the structure of involucrin is likely to be important in 
determining its role in cornified envelope formation. Involucrin 
displays a uniform circumferential distribution of Gin residues at 
equal intervals along the axis of the a-helical involucrin rod, sug-
gesting that involucrin should be able to cross-link proteins in multi-
ple spatial planes [26]. Because the rod is highly extended it is likely 
to be able to cross-link proteins separated by substantial distances 
within the envelope (i.e., proteins separated by 460 A). For com pari-
son, the width of the plasma membrane bilayer and the cornified 
envelope are 40 and 120 A, respectively. The uniform distribution 
of multiple glutamine residues along the length of the a-helical rod 
segment suggests that each individual involucrin molecule is likely 
to cross-link multiple amine donors [2,15,22,25]. In fact, the num -
ber of proteins cross-linked to each involucrin molecule may be 
limited only by steric hindrance (i.e., previously cross-linked pro-
teins may make it more difficult for each subsequent substrate pro-
tein, as well as TG, to obtain access to involucrin). Third, because it 
is a soluble molecule, involucrin is likely to be deposited on the 
cytoplasmic face of the plasma membrane. Fourth , it has been re-
ported that a preferred site of cross-link formation in vitro is Gl11.j96 
l37], suggesting that Gln496 may be a first site to be cross-linked ill 
vivo. Fifth, indirect evidence for the presence of multiple cross-
linked species in envelopes prepared from cultured cells [22] sug-
COOH 
Figure 2. Struaure of human involucrin. A model of involucrin structure based on results d~rived from e1~ctron microsco!,y. computer modeling and CD 
[26], scdllnentatlon centrifugation and gel permeation [21 ], and blOchemtcallabehng [37] expenments. a-hebcal segments are IIldtcated as open rectallgles joined 
by short segments of random coil (lili es) The end domains consist of segments of p-sheet (dark arrows) interspersed with segments of random coil. Closed sqtlarr, 
the major ill vitro cross-link site, Gln49 •. Opell sYlllbols, moderately utilized sites of cross-link formation. Bracketed regio ll (asterisk) is a region of poor reactivity 
toward TG [37]. 
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I'S shown as a dasiJed lilJe. Potential glutamyl donor sites are presented as 
ucn . I d' I h t lines wrapped around the central rod domam. B shows t 1e perpen ICU ar 
! °d arallel models describing two ways in which involucrin could be lncor-
all tIred as parr of the marginal band. In both models it is assumed that 
po lucrin is anchored to the plasma membrane by membrane-bound TG-
JDvo . . b d . d diated cross-Imbng to one or more membrane- oun am me onot pro-
Jll~ The solid black circles depict additional proteins that subsequently be-EeU1S~ cross-linked to involucrin possibly by calcium-activated soluble TG 
':dicated by an opell square with the active site depicted by an illlier dark 
( ) Involucrin may be cross-Imked to cormfin [17] or the pancortlulll1s 
sqJlare . I d . . d' db I I I' fI k' [20]. Potential glutamy onor sites are 111 \Cate y t 1e s JOrt JIles an II1g 
Ebe involucnn rod. 
that the cross-l inking process is progressive (i .e., additional 
gestS . d . I . ) 
cross-link sites are recrUite Wit 1 t1Ine . 
THE ROLE OF TG ACTIVITY 
'these properties of involucrin must be considered in the context of 
hat is known regarding TG interaction with its substrates [1 2-
74,38 - 40]. The available information suggests that TG does not 
cognize substrates based only on the pnmary am1110 aCid sequence [~2,37,40], but that secondary and/or tertiary structure may be 
more important [12,37,40,41]. It also appears necessary that tl~e 
active glutamine be exposed on the surface of the substrate protem 
SO as to be accessibl e to TG and that the~e be an absence of charged 
esidues at specific posltions on either Side of t he target glutamme 
[41]. Nearly all ofthe glutamine residues on involucrin appear to be 
adequately exposed; ho.wever, not all ~p'pear .to conform to th.e 
charge distribution reqU\re~nents. An addlt~onal \l1'~portant feature IS 
[he localization of the various TG forms 111 keratmocytes. At least 
e of the forms is syntheSized as a cytoplasmIC protem and then IS ~~chored to the inner surface of the plasma membrane following 
addition of a lipid anchor [34]. A second form appears to be solubl e 
[35]. 
MODELS OF INVOLUCRIN CROSS-LINKING AND 
ENVELOPE ASSEMBLY 
Figure 3A shows t,:",o possible ITI?dels describing involucrin cross-
linking. The first IS the proX1l11lty model and proposes that the 
interaction of involucrin with membrane-bound TG is gu ided by 
the location of other molecules in the environment, specifically the 
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proximity of the plasma membrane lipids. In this model, the rela-
tively hydrophobic C domain of involucrin interacts with the 
plasma membrane to position involucrin adjacent the plasma mem-
brane-bound TG, placing Gln496 in a favorable position for subse-
quent cross-linking. The high negative charge density on the invo-
lucrin rod may force the rest of the molecule away from the pl asma 
membrane. Formation of the initial involucrin-acyl enzyme linkage 
near the C -terminal end of the a-helical region at Gln496 i'l vitro [37] 
may simply reflect the fact that the C-terminal hydrophobic do-
m ain is sma ll er than the N-terminal hydrophobic domain. This 
could allow the C -terminal end of involucrin to position more 
efficiently in the vicinity of the lipid-anchored TG, given the pres-
ence of the plasma m embrane lipids (i.e., the larger size of the 
N-terminal hydrophobic domain m ay prevent the amino terminus 
from positioning for cross-linking). This model minimizes the role 
of involucrin primary, secondary, and tertiary structure, per se, in the 
selection of the specific Gin residue for formation of the initial acyl 
enzyme link and assumes that involucrin is cross-linked to mem-
brane-bound envelope precursors. This is a credible hypothesis, as 
several membrane-bound precursors have been described [23] and a 
form of TG has been localized to the inner surface of the plasma 
membrane [34] . It is worth noting that the selection of the primary 
amine-containing protein for the second step in the reaction, the 
transfer of involucrin to a m embrane protein-bound primary amine, 
may also be guided by these same constraints. The plaus ibility of 
such a proximity model is supported by the fact that prepositioning 
of substrates prior to transglutaminase cross-linking appears to 
be important in the clot-forming system [41,42] , which also in-
volves TG. 
In an alternative model, the conformationa l model, the major 
factors that determine the site of formation of the acyl enzyme 
linkage with invo lucrin are structural features inherent in the invo-
lucrin protein. This model de-emphasizes the role of other mole-
cules and structures in the im.mediate vicinity and emphasiz.es the 
twO- and three-dimensional features of involucrin. Perhaps TG 
binds to involucrin on a specific location , which in turn positions 
the active site at G ln496 for subsequent cross-link formation by TG . 
In this regard, it is interesting that involucrin contains a series of 
repeats that are nearly identical [1 5]. This suggests that TG must 
discriminate among some very similar choices for formation of each 
cross-lil~k. T his feature supports the conclusion that the secondary 
and tertiary structure of 1I1volucnn and charge distribution around 
reactive glutamme targets [43] may play an important role in cross-
link site selection. 
The location of the cross-linked involucrin after the initial cross-
lil~k is formed is also of importance. Assuming that all of the involu-
cnn IS ~ocated on the cytoplasmic side of the envelope and that 
Gln496 IS the site of 1I1lt1al cross-link formation [37] , involucrin 
could be .onented perpendicular or parallel to the plane of the mem-
brane (Fig 3B) . Although it is not yet possible to distinguish be-
tweenthese models, the perpendicular orientation is appealing be-
cause It allows for charge repulsion between adjacent negatively 
charged 1I1volucnn molecul es. These perpendicularly oriented in-
volucnn molecules could then be available in the intracellular space 
for additional amme donors that would then become cross-linked to 
additional involucrin glutamine residues to further build the enve-
lope. This model also assumes that inter-involucrin cross-links 
would not be formed with high frequency, a possibility that is 
supported by the observation that involucrin does not function as an 
amine donor ill I'.itro.· In addition, the perpendicular model in Fig 
3B may convert mto the parallel model due to physical forces ap-
plied to the envelope as it fl attens. That the perpendicular model 
cannot be the final product is supported by electron microscopic 
results indicating that the envelope is 100-120 A thick (approxi-
mately four times thinner than the length of the involucrin ll'-helt-
• Bilodeau EB, Dvedar JC, Daryanani HA, Baden HP, Lorand L: Amine 
donor/acceptor relationships among cytosolic substrates of kcratinocyte 
transglutaminase (abstr). J Invest Dermatol 98:568, 1992. 
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cal rod). These models are not meant to imply that all other soluble 
precursors are cross-linked to involucrin or that all involucrin mole-
cules are directly linked to membrane proteins. It is possible that 
cornifin, for example, is also directly cross-linked to membrane 
proteins; however, experiments to demonstrate such an interaction 
have not yet been reported. 
These model s may require a second form ofTG that is not mem-
brane anchored. It is expected that the membrane-bound form 
would initiate envelope formation; however, a soluble form may be 
necessary to build the envelope into the depth of the cytoplasm. The 
membrane-bound form ofTG is known to be phosphorylated [44J 
and it is possible that this modulates its interaction with substrates or 
catalytic activity. Such a scenario could explain why envelope assem-
bly is restricted to the region beneath the plasma membrane. 
A soluble form of TG has been described in keratinocytes [35], 
and additional soluble TG could be generated by release of mem-
brane-bound transglutaminase from the membrane [45J. Thus, the 
presence of a soluble form ofTG would in principle solve a problem 
in envelope assembly. Presl)mably, at some point in enve lope for-
mation, the plasma membrane would be significantly fragmented, a 
change that may coincide with assembly of a substantial envelope. A 
membrane-bound TG under these circumstances may not have the 
mobility or steric freedom to provide additional cross-linking activ-
ity. A soluble form would presumably remain available under these 
conditions. This suggests that both soluble and membrane-bound 
forms of TG could have an important role in cross-linking involu-
crin, as well as other constituents of the cornified envelope. 
WHY USE SOLUBLE PRECURSORS TO INITIATE 
ENVELOPE ASSEMBLY 
It is important to consider the advantages and disadvantages of using 
soluble hydrophilic or insoluble hydrophobic envelope precursors 
at particular times during envelope assembly. We argue that the use 
of a soluble envelope precursor, such as involucrin, to initiate assem-
bly of the cornified envelope may have specific intrinsic advantages. 
The available evidence suggests that suprabasal cells initiate enve-
lope formation while they are still metabolically active (i.e., they 
have a nucleus and organell es) [36J. Metabolic activity requires the 
presence of a functional plasma membrane to maintain ionic gra-
dients, etc. The major advantage to the keratinocyte of using a 
soluble precursor to initiate envelope formation is that the initial 
deposition of cross-linked material can be achieved without prema-
turely compromising plasma membrane function (i.e., incorpora-
tion of large amounts of an insoluble, lipophilic precursor into the 
plasma membrane may compromise membrane integrity). This is 
important, because preparation for envelope assembly appears to be 
a relatively slow process as evidenced by the fact that, in vivo, it takes 
a single keratinocyte at least 10 d to progress from the basal layer to 
the skin to the surface of the living layers [46J. Premature cell death 
could compromise the assembly process and result in an abnormal 
epidermis. Insoluble hydrophobic precursors, in contrast, are likely 
to be useful later in envelope assembly. Information avai lable for 
one such precursor, loricrin, suggests that it is contained in vesicles 
and is not released until late in th e differentiation process [32]. By 
this time, in the upper granular layer and transition zone, the cell is 
prepared to terminally differentiate and plasma membrane integrity 
is likely to be less important. It is also likely that soluble TG [35J has 
an important rol e late in envelope assembly . During the terminal 
steps in differentiation, the membrane-bound form of TG may be 
less important, because it may be confined to lipid pockets 
surrounded by cross-linked protein. In contrast, the soluble form is 
likely to be free to complete the envelope-assembly process. Based 
on these arguments, we propose that envelope assembly proceeds as 
outlined in Table 1. 
A CRITICAL ROLE FOR INVOLUCRIN 
IN ENVELOPE ASSEMBLY 
The recent expression of human involucrin in transgenic mice may 
help to elucidate the role of altering the level and/or structure of the 
envelope precursor on epidermal function [4 7J. The epidermal kera-
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Table I. Proposed Steps in Assembly of the Keratinocyte 
Cornified Envelope 
Precursors 
Location 
Catalyst 
Cell layers 
Phase 1-
Deposition of 
Soluble Precursors 
Involucrin 
Cornifin 
Membrane-bound precursors 
(Others?) 
Inner surface of plasma 
membrane 
Membrane-bound TG 
Upper spinous and 
granular 
Phase 2-
Deposition of 
Insoluble Precursors 
Loricrin 
(Others?) 
Inner and/or outer surface 
of initial scaffolding 
Membrane-bound and 
soluble TG 
Upper-granular layer and 
transition zone 
tinocytes in these mice appear to contain two to four times as much 
soluble involucrin compared to human epidermal foreskin keratino-
cytes [47J. However, the mouse cornified envelopes appear to con-
tain 10 to 15 times more human invol ucrin per unit area of marginal 
band, as determined using immunoelectron microscopy, when 
compared to envelopes prepared from human keratinocytes 
(Murthy and Eckert, unpublished). The epidermis of these mice 
exhibits scaling and an abnormal hair phenotype [47]. The most 
likely explanation for these effects is excessive formation of is 0 pep-
tide bonds resulting from the presence of excess involucrin sub-
strate, although it is also possible that the human and mouse involu-
crin molecules are different enough that expression of human 
involucrin distorts the structure of the mouse cornified envelope. In 
either case, these results suggest that altering the abundance or type 
of envelope precursor in the envelope may be deleterious to the 
function of the epidermis. 
SUMMARY 
Recent findings have revealed much about the structure of involu-
crin. These findings make it possible to propose specific models 
regarding the role of involucrin and the mechanism of its cross-
linking as an envelope precursor. These models provide clearly test-
able hypotheses that are expected to provide additional insights into 
the mechanism of cornified envelope assembly. 
Tilis UJork was supported by grallts from tir e Natiollal IlIStitutes of Health 
(AR41456 alld CM43751, RLE) alld utilized tire fac ilities of the Skill Diseas('j 
Resea rch Cetlter of Nortlleast Oilio (NIH AR49750). 
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